Konica Minolta Inc. acquired Ambry Genetics Corp. in $1 billion deal aimed at building a precision medicine platform. Konica, headquartered in Tokyo, will pay $800 million at close of the deal, and $200 million over the next two years if financial milestones are met. Innovation Network Corp. of Japan also helped to fund the purchase. Read More
